An interventional study of Victory Patch with Haptic Vibrotactile Trigger Technology and Sham patch in VO2max, Lactate Threshold and Lactate, sponsored by SuperPatch Limited LLC. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-20.
Sponsored by SuperPatch Limited LLC · Not applicable, Interventional, and Basic science
This study aims to compare determinants of endurance performance between participants wearing an active patch with haptic vibrotactile trigger technology (VTT) versus a placebo patch without VTT among recreational to competitive runners over a 4-week training period.
SuperPatch Limited LLC is the lead sponsor of 7 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Victory Patch
Device: Victory Patch with Haptic Vibrotactile Trigger Technology
Sham Comparator
Device: Sham patch
Active Patch with Haptic Vibrotactile Trigger Technology
Sham/Placebo Patch without Haptic Vibrotactile Trigger Technology
Change in VO2 Max
Change in VO₂max (mL/kg-¹/min-¹, calculated as a 30-second rolling average)
Time frame: 2-weeks and 4-weeks after baseline assessment
Change in Lactate-threshold running speed
Measurement of Lactate-threshold running speed using capillary sampling (LT, km/h-¹), determined using a DmodMax algorithm on lactate-speed curves \[15\], (2) serum lactate level at threshold (mmol·L-¹).
Time frame: 2-weeks and 4-weeks after baseline assessment
Plan to share: Yes
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: Upon Initiation of the Study
Access criteria: Current Study Investigators and associated Research Staff
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.